skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Refinado por: Base de dados/Biblioteca: HighWire Press (Free Journals) remover assunto: Life Sciences & Biomedicine remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
New-onset saquinavir-induced diabetes
New-onset saquinavir-induced diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

New-onset saquinavir-induced diabetes

van Zoelen, Marieke A D ; Hoepelman, A I M ; de Valk, H W

Diabetes care, 2013-12, Vol.36 (12), p.e199-e199 [Periódico revisado por pares]

United States: American Diabetes Association

Texto completo disponível

Citações Citado por
2
Altered Myocellular and Abdominal Fat Partitioning Predict Disturbance in Insulin Action in HIV Protease Inhibitor-Related Lipodystrophy
Altered Myocellular and Abdominal Fat Partitioning Predict Disturbance in Insulin Action in HIV Protease Inhibitor-Related Lipodystrophy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Altered Myocellular and Abdominal Fat Partitioning Predict Disturbance in Insulin Action in HIV Protease Inhibitor-Related Lipodystrophy

Gan, Seng Khee ; Samaras, Katherine ; Thompson, Campbell H ; Kraegen, Edward W ; Carr, Andrew ; Cooper, David A ; Chisholm, Donald J

Diabetes (New York, N.Y.), 2002-11, Vol.51 (11), p.3163-3169 [Periódico revisado por pares]

Alexandria, VA: American Diabetes Association

Texto completo disponível

Citações Citado por
3
Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis
Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis

Ribera, Esteban ; Azuaje, Carlos ; Lopez, Rosa M. ; Domingo, Pere ; Curran, Adria ; Feijoo, Maria ; Pou, Leonor ; Sánchez, Paquita ; Sambeat, Maria Antonia ; Colomer, Joan ; Lopez-Colomes, Josep Lluis ; Crespo, Manuel ; Falcó, Vicenç ; Ocaña, Imma ; Pahissa, Albert

Journal of antimicrobial chemotherapy, 2007-04, Vol.59 (4), p.690-697 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
4
Drug-Drug Interaction Study of Ketoconazole and Ritonavir-Boosted Saquinavir
Drug-Drug Interaction Study of Ketoconazole and Ritonavir-Boosted Saquinavir
Material Type:
Artigo 		Adicionar ao Meu Espaço

Drug-Drug Interaction Study of Ketoconazole and Ritonavir-Boosted Saquinavir

KAESER, Benoite ; ZANDT, Hagen ; BOUR, Fabrice ; ZWANZIGER, Elke ; SCHMITT, Christophe ; XIAOPING ZHANG

Antimicrobial Agents and Chemotherapy, 2009-02, Vol.53 (2), p.609-614 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

Citações Citado por
5
The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy
The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy

Staszewski, Schlomo ; Babacan, Errol ; Stephan, Christoph ; Haberl, Annette ; Carlebach, Amina ; Gute, Peter ; Klauke, Stephan ; Hermschulte, Yvonne ; Stuermer, Martin ; Dauer, Brenda

Journal of antimicrobial chemotherapy, 2006-11, Vol.58 (5), p.1024-1030 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
6
Association of Saquinavir Plasma Concentrations with Side Effects but Not with Antiretroviral Outcome in Patients Infected with Protease Inhibitor-Susceptible Human Immunodeficiency Virus Type 1
Association of Saquinavir Plasma Concentrations with Side Effects but Not with Antiretroviral Outcome in Patients Infected with Protease Inhibitor-Susceptible Human Immunodeficiency Virus Type 1
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association of Saquinavir Plasma Concentrations with Side Effects but Not with Antiretroviral Outcome in Patients Infected with Protease Inhibitor-Susceptible Human Immunodeficiency Virus Type 1

LÖTSCH, Jörn ; HARDER, Sebastian ; STÜRMER, Martin ; DOERR, Hans-Wilhelm ; GEISSLINGER, Gerd ; STASZEWSKI, Schlomo ; VON HENTIG, Nils

Antimicrobial Agents and Chemotherapy, 2007-09, Vol.51 (9), p.3264-3272 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

Citações Citado por
7
Safety and Pharmacokinetics of Once-Daily Regimens of Soft-Gel Capsule Saquinavir plus Minidose Ritonavir in Human Immunodeficiency Virus-Negative Adults
Safety and Pharmacokinetics of Once-Daily Regimens of Soft-Gel Capsule Saquinavir plus Minidose Ritonavir in Human Immunodeficiency Virus-Negative Adults
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and Pharmacokinetics of Once-Daily Regimens of Soft-Gel Capsule Saquinavir plus Minidose Ritonavir in Human Immunodeficiency Virus-Negative Adults

KILBY, J. Michael ; SFAKIANOS, Greg ; GIZZI, Nick ; SIEMON-HRYCZYK, Peggy ; EHRENSING, Eric ; OO, Charles ; BUSS, Neil ; SAAG, Michael S

Antimicrobial Agents and Chemotherapy, 2000-10, Vol.44 (10), p.2672-2678 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

Citações Citado por
8
Clinical Response and Tolerability to and Safety of Saquinavir with Low-Dose Ritonavir in Human Immunodeficiency Virus Type 1-Infected Mothers and Their Infants
Clinical Response and Tolerability to and Safety of Saquinavir with Low-Dose Ritonavir in Human Immunodeficiency Virus Type 1-Infected Mothers and Their Infants
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical Response and Tolerability to and Safety of Saquinavir with Low-Dose Ritonavir in Human Immunodeficiency Virus Type 1-Infected Mothers and Their Infants

ZORRILLA, Carmen D ; VAN DYKE, Russell ; MCSHERRY, George ; MOFENSON, Lynne ; BARDEGUEZ, Arlene ; ACOSTA, Edward P ; SMITH, Betsy ; HUGHES, Michael D ; HUANG, Sharon ; WATTS, D. Heather ; HECKMAN, Barbara ; JIMENEZ, Eleanor

Antimicrobial Agents and Chemotherapy, 2007-06, Vol.51 (6), p.2208-2210 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

Citações Citado por
9
Clinical and Pharmacokinetic Data Support Once-Daily Low-Dose Boosted Saquinavir (1,200 Milligrams Saquinavir with 100 Milligrams Ritonavir) in Treatment-Naive or Limited Protease Inhibitor-Experienced Human Immunodeficiency Virus-Infected Patients
Clinical and Pharmacokinetic Data Support Once-Daily Low-Dose Boosted Saquinavir (1,200 Milligrams Saquinavir with 100 Milligrams Ritonavir) in Treatment-Naive or Limited Protease Inhibitor-Experienced Human Immunodeficiency Virus-Infected Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical and Pharmacokinetic Data Support Once-Daily Low-Dose Boosted Saquinavir (1,200 Milligrams Saquinavir with 100 Milligrams Ritonavir) in Treatment-Naive or Limited Protease Inhibitor-Experienced Human Immunodeficiency Virus-Infected Patients

MARIN-NIEBLA, Ana ; LOPEZ-CORTES, Luis Fernando ; RUIZ-VALDERAS, Rosa ; VICIANA, Pompeyo ; MATA, Rosario ; GUTIERREZ, Alicia ; PASCUAL, Rosario ; RODRIGUEZ, Magdalena

Antimicrobial Agents and Chemotherapy, 2007-06, Vol.51 (6), p.2035-2042 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

Citações Citado por
10
Assessing Safety and Efficacy of Directed P-Glycoprotein Inhibition to Improve the Pharmacokinetic Properties of Saquinavir Coadministered with Ritonavir
Assessing Safety and Efficacy of Directed P-Glycoprotein Inhibition to Improve the Pharmacokinetic Properties of Saquinavir Coadministered with Ritonavir
Material Type:
Artigo 		Adicionar ao Meu Espaço

Assessing Safety and Efficacy of Directed P-Glycoprotein Inhibition to Improve the Pharmacokinetic Properties of Saquinavir Coadministered with Ritonavir

Huisman, Maarten T ; Smit, Johan W ; Wiltshire, Hugh R ; Beijnen, Jos H ; Schinkel, Alfred H

The Journal of pharmacology and experimental therapeutics, 2003-02, Vol.304 (2), p.596-602 [Periódico revisado por pares]

United States: American Society for Pharmacology and Experimental Therapeutics

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2000  (2)
  2. 2000Até2001  (3)
  3. 2002Até2005  (2)
  4. 2006Até2009  (7)
  5. Após 2009  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.